APAC Ocular Implants Market

The Asia Pacific Ocular Implants Market size is expected to grow at a healthy CAGR between 2022 and 2027.

Ocular implants are used to treat diseases and problems of the eyes. In the future years, increased investment in the research and development of newer goods will directly impact market growth. The developments in ophthalmic diagnostic technologies have resulted in a greater acceptance of the products. The ease with which online tools have educated the public about various treatment alternatives will increase the market's growth. The increasing usage of innovative ocular technologies such as artificial eyes devices has created an excellent opportunity for market players. The growing number of ocular device regulatory clearances will aid leading businesses in generating significant ocular implants market revenue.

Patients can be advised to develop timely eye care if they are aware of prevalent eye disorders and treatments. This can assist in reducing the burden of visual impairment. In addition, the incidence of diabetes and obesity is on the rise, leading to an increase in the number of persons with vision impairment. Therefore, governments are implementing various health education programs to raise knowledge about preventing these diseases and the available treatments. VISION 2020: The Right to Sight, for example, was founded in 1999 to lower the global burden of preventable blindness, particularly in emerging nations like India.

The APAC ocular implants market is further expected to grow due to increased public awareness and government initiatives for vision care management. Other advancements include advanced corneal implants that address difficulties with currently implanted devices. In addition, the ocular prosthesis provides a facial aesthetic appeal to persons who have damaged their eyes. There are several types of glass, plastic, and scleral shell implantable ocular prostheses in the market. Furthermore, the expanding trend of using cryolite glass for ocular prosthetics boosts the market for ocular implants.

The difficulty of implantation and post-implantation and the harmful effects of ocular implants may prove to be a substantial impediment to market growth. Lower treatment rates and accessibility of such devices in this nation are two main challenges impeding market expansion. Furthermore, the lengthy regulatory approval process inhibits the timely launch of new products on the market. In addition, recent ocular implant product recalls may make it more difficult for the general public to accept these devices.

This research report on the APAC Ocular Implants Market has been segmented and sub-segmented based on the following categories:

By Implant Type:

• Intraocular lenses
• Corneal implants 
• Glaucoma implants       
• Orbital implants  
• Ocular prosthesis
• Others   

By Application:

• Glaucoma Surgery
• Oculoplasty
• Drug Delivery
• Age-Related Macular Degeneration
• Aesthetic Purpose
• Others

By End User:

• Hospitals
• Specialty Eye Clinics
• Eye Institutes

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, the Asian market is predicted to grow quickly because of an increase in the diabetes population and higher government healthcare spending. In addition, because the number of reported cases of blindness is increasing, cataract operations are becoming more common, and individual and government expenditure on eye care is increasing; developing countries like China and Japan are projected to be the fastest-growing in Asia Pacific region. Increasing accessibility of intraocular lens and glaucoma devices and increased awareness of ocular illnesses are two major factors driving market expansion in the region.

KEY MARKET PLAYERS:

Companies that dominate the ocular implants market in the APAC region profiled in this report are Bausch & Lomb, Alcon, Carl Zeiss, Johnson & Johnson, MORCHER GmbH, and STAAR Surgical.